33 results on '"Rossi, Davide"'
Search Results
2. Marginal zone lymphomas
3. Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia
4. Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib
5. Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia
6. Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia
7. IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC
8. Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia.
9. Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients
10. The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15‐ICML workshop on ctDNA
11. Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden
12. The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.
13. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia
14. XIII. Molecular pathogenesis of transformed lymphomas
15. BCL2mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
16. MYCnetwork mutations in high-risk chronic lymphocytic leukaemia
17. IX. Chronic lymphocytic leukaemia: New genetic markers as prognostic factors
18. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone
19. Analysis ofSF3B1mutations in monoclonal B-cell lymphocytosis
20. Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype
21. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
22. In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas
23. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas
24. Richter syndrome: molecular insights and clinical perspectives
25. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
26. Analysis of immunoglobulin heavy and light chain variable genes in post‐transplant lymphoproliferative disorders
27. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis
28. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.
29. Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype.
30. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
31. MYC network mutations in high-risk chronic lymphocytic leukaemia.
32. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.
33. Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.